Construction, purification, and characterization of a chimeric TH1 antagonist. - Test2 - elhamkhani - TriplyDB

Construction, purification, and characterization of a chimeric TH1 antagonist.

Construction, purification, and characterization of a chimeric TH1 antagonist.

http://www.wikidata.org/entity/Q33244262

about

Analysis of the relationship between end-to-end distance and activity of single-chain antibody against colorectal carcinoma.Optimization modeling of single-chain antibody against hepatoma based on similarity algorithm

P2860

Q30420582-0729F636-3180-4652-AB02-704759063DC5 Q41843121-E578475D-E184-4618-8755-E4D1AD61B9E7

P2860

Construction, purification, and characterization of a chimeric TH1 antagonist.

http://www.wikidata.org/entity/Q33244262

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Construction, purification, and characterization of a chimeric TH1 antagonist.

@ast

Construction, purification, and characterization of a chimeric TH1 antagonist.

@en

type

label

Construction, purification, and characterization of a chimeric TH1 antagonist.

@ast

Construction, purification, and characterization of a chimeric TH1 antagonist.

@en

prefLabel

Construction, purification, and characterization of a chimeric TH1 antagonist.

@ast

Construction, purification, and characterization of a chimeric TH1 antagonist.

@en

P1433

Q33244262-04518CC1-B621-42DF-AC02-D70BA3E270C0

P1476

Q33244262-65419C3A-9016-4102-8A5F-406B0F189E8F

P2093

Q33244262-337943F7-FB57-429B-AC47-577A700481FA

Q33244262-3FAEF1A5-586E-480F-B30A-B1D39BC75789

Q33244262-4639234A-E8C8-42EC-AB7A-A339AA12D666

Q33244262-68F1A5B7-AA89-4346-9F20-FB9E0C2CC58C

Q33244262-69063609-08A6-4C35-B0BF-B41908FF01FB

Q33244262-8701B8C5-BFD3-4ABE-9D71-2E123D8F62AF

Q33244262-97A36668-F2D3-49CD-82FB-DD731166CBEE

Q33244262-DCE416E0-C94D-4F59-A8FD-508BF3BEC96D

P2860

Q33244262-01173BA8-FCED-4225-8F5C-D6F64E2DAF6A

Q33244262-0A4A5129-24DB-4675-A852-F3869C74977F

Q33244262-1533C44F-7EA8-4102-81D7-6A6FA97497DC

Q33244262-232F27F1-8AB1-467A-9C82-74DB36D9F609

Q33244262-251E11AA-48F9-4FC3-A3F1-7FB088ECEA0E

Q33244262-2965322B-297D-477A-958C-B00D069C6E5B

Q33244262-2A5C1F36-4639-4786-95AF-1E295052202E

Q33244262-3F67B7F5-D9FD-4019-B15E-EEBF569B3ADA

Q33244262-456DCE3B-F7A9-45BF-BA93-777632BD053E

Q33244262-47A4A814-7B3D-409B-922A-FB6AACDD8D55

P2888

Q33244262-5C3834AD-AF84-4DEB-931C-6C7D10521BF5

P304

Q33244262-DE16CA35-1D57-49D0-A5C3-D4BDA6F7B2C0

P31

Q33244262-D70FF9CE-3DF3-47FB-A64F-83DE978C2025

P356

Q33244262-E8FE231F-C027-4E2F-9C0D-83CAEA07BD16

P478

Q33244262-C184BF47-C29E-40E5-BE9C-D5DB83DEEA10

P577

Q33244262-363F6DFF-935E-4115-8F97-C8C81E204F70

P5875

Q33244262-61C60302-45E2-41E7-BB80-52288A09FBE2

P6179

Q33244262-F95D6A1C-D4A4-4BCC-9BBC-A34064AF109C

P698

Q33244262-06D509AC-EFCC-487B-8195-F7C605588C4A

P932

Q33244262-FE63A944-EF47-40C1-86C3-70B11E3E9CC9

P356

P1433

BMC Biotechnology

P1476

Construction, purification, and characterization of a chimeric TH1 antagonist.

@en

P2093

Elizabeth Blanco-Garcés

http://www.w3.org/2001/XMLSchema#string

Giselle Pentón-Rol

http://www.w3.org/2001/XMLSchema#string

Haydee Gerónimo-Perez

http://www.w3.org/2001/XMLSchema#string

Iraldo Bello-Rivero

http://www.w3.org/2001/XMLSchema#string

Luís Javier-González

http://www.w3.org/2001/XMLSchema#string

Osmani Fernández-Batista

http://www.w3.org/2001/XMLSchema#string

Pedro López-Saura

http://www.w3.org/2001/XMLSchema#string

Yeny Torrez-Ruiz

http://www.w3.org/2001/XMLSchema#string

P2860

The IL-2 receptor complex: its structure, function, and target genes

The quantal theory of how the immune system discriminates between "self and non-self"

Neutralizing epitopes on the extracellular interferon gamma receptor (IFNgammaR) alpha-chain characterized by homolog scanning mutagenesis and X-ray crystal structure of the A6 fab-IFNgammaR1-108 complex

The IFN gamma receptor: a paradigm for cytokine receptor signaling

Error-tolerant identification of peptides in sequence databases by peptide sequence tags

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Purification and partial characterization of a receptor protein for mouse interferon gamma.

The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells

Detection of biomolecules in electrophoresis gels with salts of imidazole and zinc II: a decade of research.

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

P2888

P304

25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1472-6750-6-25

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7065988

http://www.w3.org/2001/XMLSchema#string

P6179

1033758763

http://www.w3.org/2001/XMLSchema#string

P698

16716222

http://www.w3.org/2001/XMLSchema#string

P932

1481661

http://www.w3.org/2001/XMLSchema#string